Long-Term Effects of Overuse of an Inhaler for Asthma
Taking a medicine more frequently or at higher doses than is prescribed without consulting a doctor is not a good idea -- and most people know this. However, what exactly are the long-term risks of overusing an asthma inhaler? Well, it depends on what, specifically, is being overused. ... [Continue here to preview what you are going to talk about very generally -- but don't state anything here that you would restate later.]
If you are experiencing serious medical symptoms, seek emergency treatment immediately.
Types of inhaled asthma medications
Two classes of inhaled asthma medications are commonly prescribed in the treatment of asthma: Beta2 (β2)-agonists and corticosteroids. Both classes are considered safe as long as they are taken as directed.
Short-acting β2-agonists
List of Asthma Inhalers, Ingredients and How They Work
Learn More
Short acting β2-agonists, sometimes called rescue inhalers, relax and dilate airways to increase airflow. Short-acting β2-agonists such as albuterol and terbutaline provide immediate relief of airway constriction that lasts up to 8 hours. Clinicians commonly refer to this class of drugs as “rescue therapy” because it should only be administered during acute attacks. β2-agonists are considered safe as long as they are not being used more than twice a week (except in exercised-induced asthma). The National Heart, Lung and Blood Institute cautions that overuse of short-term β2-agonists indicates that asthma is not well-controlled and that the current treatment plan must be re-evaluated 2. Patients who exceed dosing recommendations may experience worsening and reduced control of asthma symptoms.
- Short acting β2-agonists, sometimes called rescue inhalers, relax and dilate airways to increase airflow.
- β2-agonists are considered safe as long as they are not being used more than twice a week (except in exercised-induced asthma).
Long-term β2-agonists
Long-term β2-agonists, such as salmeterol and formotoerol, also increase airflow to the lungs by relaxing and dilating airways. They provide up to 12 hours of relief from airway constriction. The Salmeterol Multicenter Asthma Research Trial (SMART) investigated the safety of long-term β2-agonists and demonstrated that they should not be prescribed as a monotherapy due to: • Increased risk of asthma-related death and life-threatening events • Reduced response to rescue therapy • Cardiovascular side effects that increase with duration of use, including increased heart rate, palpitations, arrhythmias and congestive heart failure β2-agonists are however considered safe when prescribed in conjunction with low-dose inhaled corticosteroids.
Inhaled corticosteroids
List of Nebulizer Medications and Ingredients
Learn More
Inhaled corticosteroids improve asthma symptoms by decreasing airway inflammation. They provide long-term asthma control when prescribed alone or in combination with long-term β2-agonists as maintenance therapy. Corticosteroids are generally considered safe in low-to-medium doses; however, extended use of higher doses in children have been linked to: • Suppression of hypothalamus, pituitary and adrenal gland function • Reduced growth rate and lower adult height
Related Articles
References
- National Asthma Education and Prevention Program: Expert Panel 3 Report
- National Heart, Lung and Blood Institute Current Asthma Guidelines
- Franks TJ, Burton DL, Simpson MD. Patient medication knowledge and adherence to asthma pharmacotherapy: a pilot study in rural Australia. Ther Clin Risk Manag. 2005;1(1):33–38. doi:10.2147/tcrm.1.1.33.53598
- Vernon MK, Wiklund I, Bell JA, Dale P, Chapman KR. What do we know about asthma triggers? A review of the literature. J Asthma. 2012;49(10):991-8. doi:10.3109/02770903.2012.738268
- Jiménez-ruiz CA, Andreas S, Lewis KE, et al. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J. 2015;46(1):61-79. doi:10.1183/09031936.00092614
- Mastronarde JG. Is There a Relationship Between GERD and Asthma? Gastroenterol Hepatol (N Y). 2012;8(6):401-3.
- Dogra S, Kuk JL, Baker J, Jamnik V. Exercise is associated with improved asthma control in adults. Eur Respir J. 2011;37(2):318-23. doi:10.1183/09031936.00182209
- Barnes PJ. Inhaled Corticosteroids. Pharmaceuticals (Basel). 2010;3(3):514-540. doi:10.3390/ph3030514
- Beasley R, Martinez FD, Hackshaw A, Rabe KF, Sterk PJ, Djukanovic R. Safety of long-acting beta-agonists: urgent need to clear the air remains. Eur Respir J. 2009;33(1):3-5. doi:10.1183/09031936.00163408
- Gadde D, Creticos P, Beakes D, et al. Adverse Effects Associated with Leukotriene Antagonist Therapy. Journal of Allergy and Clinical Immunology. 2010;125(2). doi:10.1016/j.jaci.2009.12.266
- Sorkness CA, Schend VA. Monitoring for Side Effects from Treatment. Clinical Asthma. 2008:313-319. doi:10.1016/b978-032304289-5.10035-9
- Ramsahai JM, Wark PA. Appropriate use of oral corticosteroids for severe asthma. Med J Aust. 2018;209(S2):S18-S21. doi:10.5694/mja18.00134
- U.S. National Library of Medicine. Asthmanefrin. 2017.
- NIH National Center for Complementary and Integrative Health. Asthma: In Depth. Updated September 24, 2017.
- Freitas DA, Holloway EA, Bruno SS, Chaves GS, Fregonezi GA, Mendonça KP. Breathing exercises for adults with asthma. Cochrane Database Syst Rev. 2013;(10):CD001277. doi:10.1002/14651858.CD001277.pub3
- Wechsler ME, Kelley JM, Boyd IO, et al. Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med. 2011;365(2):119-26. doi:10.1056/NEJMoa1103319
- Medici TC, Grebski E, Wu J, Hinz G, Wüthrich B. Acupuncture and bronchial asthma: a long-term randomized study of the effects of real versus sham acupuncture compared to controls in patients with bronchial asthma. J Altern Complement Med. 2002;8(6):737-50. doi:10.1089/10755530260511748
- National Center for Complementary and Integrative Health. Asthma: In Depth.
- Wechsler ME, Kelley JM, Boyd IOE, et al. Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma. New England Journal of Medicine. 2011;365(2):119–126. doi:10.1056/NEJMoa1103319
- Wilhelm CP, Chipps BE. Bronchial Thermoplasty: A Review of the Evidence. Ann Allergy Asthma Immunol. 2016;116:92-98. doi:10.1016/j.anai.2015.11.002
- Centers for Disease Control and Prevention. Consumer Information. Asthma.
- Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma.
Writer Bio
Tanya Feke is a board-certified family physician with interests in preventive medicine, lifestyle modification and women's health. Her book "Medicare Essentials" is an Amazon bestseller. She has been published in the journal "Medical Economics" and has managed her educational website Diagnosis Life (www.diagnosislife.com) since 2010.